Western academic announced as Chair of the Financial Planning Education Council
Associate Professor Sharon Taylor from the School of Business at Western Sydney University has been appointed as Chair of the Financial Planning Education Council (FPEC).
With an outstanding track record in both teaching and research since 1995, Associate Professor Taylor has established a reputation as a leading academic in the financial planning sector.
“It is an honour to work with the FPEC to develop strong and robust financial planning education and to also promote financial planning as a distinct learning area and a career of choice,” said Associate Professor Taylor.
Financial Planning Association of Australia (FPA) Chairman, Neil Kendall CFP, said, “The FPA Board is delighted that Sharon has been appointed as the new Chair of FPEC. Sharon has been the FPEC Deputy Chair for six years and we are confident that she will be committed to the development of the financial planning profession.”
At Western Sydney University, Associate Professor Taylor has been instrumental in developing both undergraduate and postgraduate programs to meet industry requirements including RG146 and recently developing postgraduate Financial Planning programs to meet the current FPEC requirements.
She has chaired several committees and boards at university level, and has participated as Chair of the FPEC curriculum working committee and the research grants committee.
Associate Professor Taylor holds a Masters and a Bachelor Degree of Commerce from UNSW, a Certificate IV in Workplace Assessment and Training, and a Diploma in Company Directorship.
FPEC was established by the FPA in 2011 as an independent body, chartered with raising the standard of financial planning, education, and promoting financial planning as a distinct learning area and a career of choice.
Domestic violence occurs across all age groups and life stages. Rather than reducing during pregnancy, expecting a child is a key risk factor for domestic violence beginning or escalating.
Demand for drugs and devices that can enhance brain functions such as memory, creativity, attention and intelligence, is on the rise. But could the long-term side-effects outweigh the benefits of being “smarter”?
There has been a recent global rise in “green fever”, with various jurisdictions either decriminalising or legalising cannabis.